Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Arch Womens Ment Health. 2013 Oct 3;17(1):17–26. doi: 10.1007/s00737-013-0383-6

Table 4.

Relationship between pregnancy and suicide warnings and rates and trends of antidepressant prescribing (per 1,000 persons) during pregnancy, 2002–2005

Antidepressant prescribing at the start of pre- warning period, N prescriptions per 1,000 womena Rate of change in antidepressant use (pre-warning period), N prescriptions per 1,000 women/month (95% CI)b Rate of change in antidepressant use (post-warning period), N prescriptions per 1,000 women/month (95% CI)c
Any antidepressant 34.17 0.51 (0.38, 0.64) −1.00 (−1.58, −0.43)
SSRI 25.40 0.26 (0.15, 0.36) −0.66 (−1.14, −0.19)
Non-SSRI 8.77 0.25 (0.20, 0.30) −0.34 (−0.55, −0.12)
a

Represents the estimated number of antidepressant prescriptions per 1,000 pregnant women in January 2004.

b

Represents the rate of change (slope) in antidepressant prescribing during the pre-warning period (January 1, 2002 – December 31, 2003). The positive values (with 95% confidence intervals [CIs]) are rates of increase, expressed as number of prescriptions per 1,000 pregnant women per month.

c

Represents the rate of change (slope) in antidepressant prescribing during the post-warning period (November 1, 2004 – July 31, 2005). The negative values (with 95% confidence intervals [CIs]) are rates of decrease, expressed as number of prescriptions per 1,000 pregnant women per month.